Krsnaa Diagnostics Limited (BOM:543328)

Market Cap	22.72B
Revenue (ttm)	7.60B
Net Income (ttm)	845.56M
Shares Out	n/a
EPS (ttm)	25.68
PE Ratio	26.87
Forward PE	18.99
Dividend	2.75 (0.38%)
Ex-Dividend Date	Sep 12, 2025

Volume	7,380
Average Volume	1,793
Open	709.30
Previous Close	709.25
Day's Range	697.95 - 722.75
52-Week Range	628.00 - 914.95
Beta	n/a
RSI	35.33
Earnings Date	Feb 14, 2026

About Krsnaa Diagnostics

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves indivi...

• Industry: Medical Laboratories
• Founded: 2010
• Employees: 3,471
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543328

Financial Performance

In 2024, Krsnaa Diagnostics's revenue was 7.17 billion, an increase of 15.74% compared to the previous year's 6.20 billion. Earnings were 776.08 million, an increase of 36.54%.